Macromolecular prodrugs X. Kinetics of fenoprofen release from PHEA-fenoprofen conjugate

被引:16
作者
van der Merwe, T
Boneschans, B
Zorc, B
Breytenbach, J
Zovko, M
机构
[1] Ctr Qual Assurance Med, ZA-2520 Potchefstroom, South Africa
[2] Potchefstroom Univ Christian Higher Educ, Dept Pharmaceut Chem, ZA-2520 Potchefstroom, South Africa
[3] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
关键词
fenoprofen; polymer-drug conjugate; poly[alpha; beta-(N-2-hydroxyethyl-DL-aspartamide); kinetic study; HPLC;
D O I
10.1016/S0378-5173(02)00197-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The kinetics of fenoprofen release from poly[alpha,beta-(N-2-hydroxyethyl-DL-aspartamide)]-fenoprofen conjugate (PHEA-Fen) in aqueous buffer solutions (pH 10 and 1.1). simulated gastric (SGF) and intestinal fluids (SIF) was studied. In borate buffer pH 10, the following rate constants were obtained: k = 0.2659 (t = 60 degreesC) and k = 0.0177 h (-1) (t = 37 degreesC) and in glycine buffer solution pH 1.1 k = 0.0036 h (-1). In SGF and SIF fenoprofen release did not occur in significant extend within 12 h. The hydrolysis of the ester bond between the polymeric carrier and fenoprofen followed the pseudo first-order kinetics, with activation energy indicative for the breakage of a sigma bond (E-a = 100.6 kJ mol (-1)) The concentration of the released fenoprofen was determined by high performance liquid chromatography (HPLC). (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 12 条
  • [1] SYNTHESIS, CONTROLLED-RELEASE PROPERTIES AND ANTITUMOR-ACTIVITY OF ALGINATE-CIS-ACONITYL-DAUNOMYCIN CONJUGATES
    ALSHAMKHANI, A
    DUNCAN, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) : 107 - 119
  • [2] Boneschans Barend, 2002, Acta Pharmaceutica (Zagreb), V52, P37
  • [3] Duncan R, 1996, STP PHARMA SCI, V6, P237
  • [4] Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
    Duncan, R
    Coatsworth, JK
    Burtles, S
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (02): : 93 - 104
  • [5] GIAMMONA G, 1995, J CONTROL RELEASE, V33, P261, DOI 10.1016/0168-3659(94)00091-8
  • [6] Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies
    Giammona, G
    Cavallaro, G
    Fontana, G
    Pitarresi, G
    Carlisi, B
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) : 321 - 331
  • [7] Macromolecular prodrugs. VIII. Synthesis of polymer-gemfibrozil conjugates
    Lovrek, M
    Zorc, B
    Boneschans, B
    Butula, I
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 200 (01) : 59 - 66
  • [8] United States Pharmacopoeia Convention, 2000, US PHARM C, P2235
  • [9] *US PHARM CONV INC, 2000, US PHARM 24 S1, P2697
  • [10] Vasey PA, 1999, CLIN CANCER RES, V5, P83